[Federal Register Volume 73, Number 189 (Monday, September 29, 2008)]
[Notices]
[Page 56615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-22879]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 15, 2008 and published in the Federal Register 
on May 27, 2008 (73 FR 30418), Siegfried (USA), Inc., Industrial Park 
Road, Pennsville, New Jersey 08070, made application by letter to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Oripavine (9330), a basic class of controlled substance 
listed in schedule II.
    The company will use the above listed controlled substance in the 
manufacture of other controlled substance intermediates for sale to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Siegfried (USA), Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Siegfried (USA), Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

     Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-22879 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P